Niro invests in expanding test center

24 April 2005

Niro of Denmark is investing massively in an expansion of its test center at its Copenhagen head office, with new funding from the GEA Group. When complete, the facility will be the largest of its type in Europe, with over 35 different pilot plants available for its customers' use.

The test center already has a huge range of equipment for process and product evaluation including: spray drying, freeze drying, extraction, agglomeration and laboratory facilities. Over the next six months, however, it will be expanded with additional equipment including: swirl fluidizer and spray fluidizer technology specifically for drying pastes; filter cakes; and highly viscous liquids.

Niro also has a separate pharmaceutical test center at the Copenhagen site operating under full Good Manufacturing Practice standards and approved by the Danish Medical Board for the production of drugs for clinical trials. It has a clean room rating of 100,000 and the process control is full 21 CFR part 11 compliant. Equipment there includes PSD 4, PSD 1 and SD Micro to provide the widest possible range of spray drying technology for realistic testing and easy scale-up to full production.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight